ROIV - Roivant Sciences prices upsized public offering of $200M
- Roivant Sciences ( NASDAQ: ROIV ) prices an upsized underwritten public offering of 26.66M shares at a price of $7.50 per share.
- The gross proceeds are expected to be $200M.
- Underwriters have a 30-day option to purchase up to an additional ~4M shares on the same terms and conditions.
- The offering is expected to close on February 7, 2023.
For further details see:
Roivant Sciences prices upsized public offering of $200M